The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

A proposed 25% US tariff on drug imports threatens India's pharmaceutical industry, potentially disrupting the supply of ...

The Canadian pharmaceutical industry is still waiting to learn about tariffs as high as 200 per cent on exports to the U.S.

Pharma companies in India are projected to offer an average salary increment of 9.6% in 2025, slightly lower than the ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

Uncertainty looms for Indian drugmakers exporting to the US amid potential tariffs and trade discussions, impacting ...

Iraq's drug localization efforts save $1B annually, with 34 factories at full capacity & 178 new applications, says PM's ...

Evolving trade policies and tariffs strain bio/pharmaceutical manufacturers, affecting profits and operational strategies.

President Trump has imposed a 15 percent tariff on most items in a trade agreement with the European Union, with ...

Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.

No impact going forward on the Indian pharma industry due to US tariff policy: IDMA: Shardul Nautiyal, Mumbai Saturday, August 2, 2025, 08:00 Hrs [IST] US President Donald Trumps ...

The pharmaceutical industry has long protested the idea of globally linked drug prices as a threat to years of U.S. dominance ...